Issuance of Convertible Instrument Balances Certainty, Timing, and ExecutionCapital Supports Strategic Imperatives and Commercialization Initiatives Spectral AI Secures Access to $12.5 Million of New Equity Capital

SALT LAKE CITY, March 20, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the U.S. Patent and Trademark Office has granted a patent that covers the use of push-button blood collection devices for PCR-based fetal sex determination. Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device

LA JOLLA, Calif., March 20, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that two abstracts entitled “STUDY PROTOCOL TO EVALUATE MN-001’S (TIPELUKAST) EFFICACY, SAFETY AND TOLERABILITY IN SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), HYPERTRIGLYCERIDEMIA (HTG) AND TYPE-2 DIABETES MELLITUS (T2DM)” and “MN-002, THE METABOLITE OF MN-001(TIPELUKAST) PROMOTES MACROPHAGE CHOLESTEROL EFFLUX” have been accepted and selected for poster presentation at the 92nd European Atherosclerosis Society (EAS) 2024 Congress to be held May 26-29, 2024. MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society

A revolutionary approach simplifies and enhances the proteomic analysis of minimal cell quantities and liquid biopsies, setting a new standard in sensitivity, throughput, and robustness. By streamlining sample preparation for mass spectrometry, the Evotip workflow enables the seamless, cost-effective identification of proteins from biological matrices like blood plasma. This advancement paves the way for unprecedented insights into diseases at a molecular level, facilitating the discovery of precise biomarkers and therapeutic targets. Evotip based workflows not only accelerate scientific discovery but also makes state-of-the-art proteomics more accessible, promising significant strides in personalized medicine and beyond https://www.nature.com/articles/s41467-024-46777-9.epdf

NVIDIA BioNeMo, which is fueling the computer-aided drug discovery ecosystem, now features more than a dozen generative AI models and cloud services. In perhaps the healthcare industry’s most dramatic transformation since the advent of computing, digital biology and generative AI are helping to reinvent drug discovery, surgery, medical imaging and wearable devices. NVIDIA Generative AI Is Opening the Next Era of Drug Discovery and DesignNVIDIA BioNeMo, which is fueling the computer-aided drug discovery ecosystem, now features more than a dozen generative AI models and cloud services.January 8, 2024 by Kimberly Powell Share  In perhaps the healthcare industry’s most dramatic transformation since the advent of computing, digital biology and generative AI are helping to reinvent drug discovery, surgery, medical imaging and wearable devices. NVIDIA has been preparing for this moment for over a decade, building deep domain expertise, creating the NVIDIA… 

Die Informationen von Regional One Health mit Sitz in Memphis, Tennessee, in den Bereichen Geburtshilfe und Gynäkologie könnten durch einen Ransomware-Angriff auf den Technologieanbieter KMJ Health Solutions kompromittiert worden sein. Am 18. Januar teilte KMJ dem University of Tennessee Health Science Center, das Bewohner von Regional One versorgt, mit, dass sein Hosting-Anbieter Liquid Web Anzeichen […] Ransomware-Angriff eines Anbieters legt Patientendaten in einem Krankenhaus in Tennessee offen

The study, by Batbileg Bor of the ADA Forsyth Institute, Cambridge, MA, USA, tailored the novel CRISPR-Cas-based diagnostic platform Specific High-Sensitivity Enzymatic Reporter Unlocking (SHERLOCK) for the species-specific detection of oral bacterial pathogens and human papillomavirus (HPV) nucleic acids. The investigators developed a computational pipeline capable of generating guide-RNAs and species-specific gene primers suitable for SHERLOCK. These constructs were synthesized by cell-free biosynthesis systems, and their specificity and sensitivity were experimentally validated by fluorescence readings of reporter RNAs. The study achieved the detection of oral bacteria within the single-molecule range that remained specific in the presence of off-target DNA found within saliva. Furthermore, the assay was refined for detecting common oral pathogens (e.g., P. gingivalis, F. nucleatum) directly from unprocessed saliva samples. The results of the detection, when tested on 30 patient saliva samples, fully aligned with those of other… 

A research team from the Institute of Physical Chemistry of the Polish Academy of Sciences have demonstrated a unique configuration of a system based on optical tweezers – which enables long-distance manipulation of various particles and cells in lab-on-the-chip devices – to enable fast and effective diagnosis and treatment of many serious diseases. The volume of the information microfluidics can unlock, combined with its speed, accuracy and specificity can become the difference between life and death in diagnosing deadly diseases such as cancer. This possibility of early-stage diagnosis of blood cancer – better known as leukemia – was the motivation of the Polish team in building an innovative microfluidics-based diagnostic device. https://pubs.rsc.org/en/content/articlelanding/2024/lc/d3lc00733b